AU2127400A - A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof - Google Patents
A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereofInfo
- Publication number
- AU2127400A AU2127400A AU21274/00A AU2127400A AU2127400A AU 2127400 A AU2127400 A AU 2127400A AU 21274/00 A AU21274/00 A AU 21274/00A AU 2127400 A AU2127400 A AU 2127400A AU 2127400 A AU2127400 A AU 2127400A
- Authority
- AU
- Australia
- Prior art keywords
- administration
- preparation
- water
- pharmaceutical composition
- active substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN1999/000062 WO2001032143A1 (en) | 1999-11-02 | 1999-11-02 | A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and a process for preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2127400A true AU2127400A (en) | 2001-05-14 |
Family
ID=11076677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU21274/00A Abandoned AU2127400A (en) | 1999-11-02 | 1999-11-02 | A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR026101A1 (en) |
AU (1) | AU2127400A (en) |
WO (1) | WO2001032143A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100425755B1 (en) * | 2001-08-27 | 2004-04-03 | 주식회사 원진신약 | Compositions containing itraconazole and their preparation methods |
US20050232974A1 (en) * | 2004-04-19 | 2005-10-20 | Gore Makarand P | System and a method for pharmaceutical dosage preparation using jettable microemulsions |
US7202209B2 (en) * | 2005-07-13 | 2007-04-10 | Allergan, Inc. | Cyclosporin compositions |
US7297679B2 (en) * | 2005-07-13 | 2007-11-20 | Allergan, Inc. | Cyclosporin compositions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8903804D0 (en) * | 1989-02-20 | 1989-04-05 | Sandoz Ltd | Improvements in or relating to organic compounds |
DE68900991D1 (en) * | 1988-01-29 | 1992-04-23 | Sankyo Co | CYCLOSPORIN COMPOSITIONS. |
GB9113872D0 (en) * | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
EP0760237A1 (en) * | 1995-08-30 | 1997-03-05 | Cipla Limited | Oil-in-water microemulsions |
WO1998040051A1 (en) * | 1997-03-12 | 1998-09-17 | Abbott Laboratories | Lipophilic binary systems for the administration of lipophilic compounds |
ID25908A (en) * | 1998-03-06 | 2000-11-09 | Novartis Ag | EMULSION PRACTONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDES |
-
1999
- 1999-11-02 AU AU21274/00A patent/AU2127400A/en not_active Abandoned
- 1999-11-02 WO PCT/IN1999/000062 patent/WO2001032143A1/en active Application Filing
- 1999-12-01 AR ARP990106120A patent/AR026101A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001032143A1 (en) | 2001-05-10 |
AR026101A1 (en) | 2003-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2258095A1 (en) | Tetrahydrolipstatin containing compositions | |
HUP0203312A3 (en) | Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use | |
AU2002216701A1 (en) | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs | |
AU4334700A (en) | Pharmaceutical dosage form for pulsatile delivery of methylphenidate | |
AU2879100A (en) | Formulation and system for intra-oral delivery of pharmaceutical agents | |
HUP0004383A3 (en) | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient | |
AU5936400A (en) | Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same | |
AU2001232337A1 (en) | Pharmaceutical composition, reagent and method for intracerebral delivery of pharmaceutically active ingredient or labeling substance | |
AU7305594A (en) | Physiologically active substance-prolonged releasing-type pharmaceutical preparation | |
AU3076700A (en) | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient | |
HUP0203451A3 (en) | Pharmaceutical compositions of anti-tubercular drugs and process for their preparation | |
CA2315261A1 (en) | Oral pharmaceutical extended release dosage form | |
HUP0301325A3 (en) | Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition | |
HUP0303891A3 (en) | Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
AU2513900A (en) | Drug dosage unit for buccal administration of steroidal active agents | |
AU4681200A (en) | A pharmaceutical composition of concentrates for microemulsion and self-emulsifying drug delivery system | |
HUP0302319A3 (en) | Pharmaceutical composition for oral administration of active ingredient | |
CA2311450A1 (en) | Pharmaceutical aerosol compositions | |
HUP0104687A2 (en) | Methods for preparing coated drug particles and pharmaceutical formulations thereof | |
AU1307399A (en) | Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same | |
AU7032500A (en) | A process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine | |
HUP0203060A3 (en) | Sustained release complex of a peptide, process for its preparation and pharmaceutical composition containing the same | |
GB0029936D0 (en) | A pharmaceutical formulation suitable for the treatment of hepititis B, hepititis C and other viral infections of the liver and a process for its preparation | |
IL145559A0 (en) | Tolperison-containing pharmaceutical preparation for oral administration | |
AU777185C (en) | Pharmaceutical form of administration for peptides, methods for its production and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |